Search results
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 10 hours agoWith a valuation of US$47 billion (~A$71 billion), Moderna aims to leverage AI to automate functions...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
'Fighting for Approval': Barriers to Needed Medications
Medscape· 5 days agoTherapies such as growth hormones and puberty blockers often face shortages, leaving pediatric...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 5 days agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 days agos first-quarter 2024 financial results and business updates. You can access the press release issued this morning as well as the slides that we'll be...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 5 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 5 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 5 days agoThose products could range from RSV vaccines to individualized cancer treatments, which will help...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe company reaffirmed anticipated revenue of $4bn from its respiratory franchise. It now expects around $0.3bn in net sales for the first half of the...